Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FNS2E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,230
Award facts
- Contract value 100% obligated
- $35,229.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $35,229.69 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with a completion date of January 23, 2026. This firm fixed-price, competitively awarded contract carries no set-aside designation and is being performed at the awardee's Conshohocken, Pennsylvania location. BIKTARVY is an antiretroviral medication used in HIV treatment, representing part of the Defense Logistics Agency's Medical Supply Chain operations supporting military healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary $999,999,999.00 IDC with the Defense Logistics Agency through December 31, 2031, which serves as the comprehensive vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates its role as a critical vendor for military and veteran healthcare systems, with access to extensive pharmaceutical inventories including specialty medications, vaccines, and generic drugs across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FNS2E?
SPE2DR26FNS2E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FNS2E worth?
The government has obligated $35,230 on SPE2DR26FNS2E.
Is contract SPE2DR26FNS2E an order under another contract?
Yes. SPE2DR26FNS2E is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNS2E competed?
The extent of competition for SPE2DR26FNS2E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award